EAPCI Column

DOI:

EAPCI focus on the Online Educational Initiatives

EAPCI Online Educational Initiatives include the EAPCI Journal Club and EAPCI webinars. The goal of these online initiatives is to provide high-quality educational content for EAPCI members. 

The EAPCI Journal Club commenced during the 2022-2024 term and has continued with great success into the 2024-2026 term. Although the credo of the EAPCI Journal Club is #bythefellowsforthefellows, there are significant educational benefits for all members of the interventional cardiology community. The Journal Club sessions follow a standard process, in which a high-impact paper is presented by an EAPCI fellow, followed by insights and critical appraisal from a senior author of the paper or a recognised expert in the topic. EAPCI members may put forward burning questions surrounding the trial prior to the Journal Club session using the EAPCI presidential X account, and three questions which are deemed of highest value to the community are addressed by the expert during the presentation. Ongoing interaction from the audience is warmly welcomed during each Journal Club session, with questions moderated by a dedicated chat moderator acting as the voice of the interventional community in putting these questions to the expert in the room.

So far in 2025, there have been two EAPCI Journal Club sessions. The season kicked off with OCCUPI, with Thomas Johnson and Erik Rafflenbeul acting as moderator and chat moderator, respectively, and Pawel Gąsior presenting the key findings of the trial.  The session was greatly enhanced by the presence of Sung-Jin Hong, the first author of the trial, who provided his perspective, highlighting the differences between the OCCUPI trial and ILUMIEN IV as well as providing interesting insights into the use of intracoronary imaging in both East Asian and non-East Asian countries.

The second Journal Club session of 2025 took place in June, with the RHEIA trial discussed. The moderators were EAPCI President Alaide Chieffo and chat moderator Erik Rafflenbeul. Giulia Botti presented the results of the trial from the fellows’ perspective, and Hélène Eltchaninoff, the senior author, provided her valuable insights into this important study. Once again, the session was very interactive, with interesting and beneficial questions asked by the EAPCI community, leading to a very educational discussion amongst the hosts and expert.

EAPCI webinars allow a more in-depth dive into a particular topic relevant to the EAPCI community. During the “Interventional therapy for resistant hypertension: state of the art in 2025 and future perspectives” webinar, Emanuele Barbato, EAPCI Past-President, hosted Felix Mahfoud and Isabella Sudano. There was an extensive discussion and review of the current indications for renal denervation, appraisal of the contemporary trial data for the management of resistant and uncontrolled hypertension, along with a practical discussion on how to set up a successful renal denervation pathway.

Finally, a two-part webinar series focused on the management of obese patients with and without diabetes in acute coronary syndromes. Part one, hosted by EAPCI President Alaide Chieffo, focused on inpatient care, with a case presentation by Valeria Paradies and a review of the evidence from Mamas Mamas.  Finally, Konstantinos Koskinas from the European Association of Preventive Cardiology discussed the importance of a multidisciplinary approach for these patients, focusing on the importance of pharmacological therapy, including prioritising the use of antidiabetic medications with improving cardiovascular benefit and, finally, considering bariatric procedures in certain highly selected patients.

In the second of this webinar series, Thomas Luescher hosted, Jorge Sanz Sanchez presented a case, and Massimo Federico, a diabetologist, provided significant insights into the management of cardiovascular disease in patients with diabetes. Finally, Giulio Stefanini provided his insight into inflammation in acute coronary syndrome, the clinical impacts, and how this can be managed, touching on the use of GLP1-RA. 

The webinar series has been well received by the community and is available to watch on ESC 365 (esc365.escardio.org) for any members who may have missed out on the live transmissions. 

Volume 21 Number 14
Jul 21, 2025
Volume 21 Number 14
View full issue


Key metrics

Suggested by Cory

Research Correspondence

10.4244/EIJ-D-25-00025 Jul 21, 2025
Validation of the pullback pressure gradient in resting conditions
Sakai K et al

Research Correspondence

10.4244/EIJ-D-25-00068 Jul 21, 2025
Intracoronary nicardipine to induce hyperaemia
Viscusi M et al

Editorial

10.4244/EIJ-E-25-00023 Jul 21, 2025
DAPT de-escalation post-ACS: a new rule or just a new option? Lessons from the 4D-ACS trial
Cuisset T and Cayla G
free

Editorial

10.4244/EIJ-E-25-00031 Jul 21, 2025
Supersaturated oxygen therapy to reduce myocardial infarct size: time to pay attention!
Stone G and Akinmolayemi O
free

Viewpoint

10.4244/EIJ-D-24-00943 Jul 21, 2025
Factor XI inhibition for ACS patients: premises and prospects
Lopes R and Fanaroff A

State-of-the-Art

10.4244/EIJ-D-24-00387 Jul 21, 2025
Advances in coronary imaging of atherosclerotic plaques
Garcia-Garcia H et al
Trending articles
225.25

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
172.05

Focus article

10.4244/EIJY19M08_01 Jan 17, 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
Glikson M et al
free
80.05

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
47

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved